Routt E. Long Term Outcomes for Basal Cell Carcinoma Treated with Vismodegib Extended Alternate Day Dosing. J of Skin [Internet]. 2019 Mar. 11 [cited 2024 Jul. 23];3(2):150-1. Available from: https://jofskin.org/33014/index.php/skin/article/view/587